Publications

Raleigh D, Cady M, Aggarwal A, Stevers N, Zakimi N, Liu I, Mirchia K, Coukos J, Kongpracha P, Zhou Y, Nguyen M, Braman B, Leclair N, Phillips J, Chow K, Shamdasani-Sen S, Chantousti N, Choi B, Hong C, Toedebusch R, Englander R, Frankus J, Sinha D, Karner H, Rosenbluth J, Veer LV', Choudhury A, Liu SJ, Krogan N, Costello J, Anczuków O, Toedebusch C, Dickinson P, Goodarzi H, Swaney D. A proteogenomic RNA processing mechanism drives sex differences in meningioma. Research square. 2026. PMID: 42282014

Berger JI, Anderson AD, Martinez OV, Morris MI, Raja M, Lekakis LJ, Beitinjaneh A, Jimenez A, Goodman M, Wang TP, Spiegel J, Holtzman NG, Komanduri KV, Pereira D, Green D, Camargo JF. Refractory and/or Resistant Herpes Simplex Virus Mucocutaneous Infections in Adult Transplantation and Cellular Therapy Patients: A Single-Center Experience. Cureus. 2026. PMID: 42395230

Chatterjee A, Mustafa Ali MK, Bailey CM, Liu Y, Small D, Smith CC, Traer E, Wang Y, Silvestri G, Baer MR. Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitors. Leukemia. 2026. PMID: 42230959

Kennedy VE, Peretz CAC, Walia A, Chyla B, Sun Y, Hill JE, Tran E, Koh AD, Ferng TT, Pintar S, Jones M, Popescu B, Lomeli I, Chehab F, Murad N, John A, Roy RP, Olshen AB, Berryhill CA, Davis C, Angus SP, Rivera JM, Meshulam A, Stieglitz E, Joshi SK, Traer E, Dail M, Hamidi H, Altman JK, Daver NG, Levis MJ, McCloskey J, Perl AE, Smith CC. Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy. Blood. 2026. PMID: 42224378

Khan R, Sun KJ, Zuraek A, Zhang L, Leung J. An Exploration of "Near-Miss" Events in Non-Operating Room Anesthesia Locations. Anesthesia and analgesia. 2026. PMID: 42224707

Swetter SM, Johnson D, Albertini MR, Barker CA, Bateni S, Baumgartner J, Bhatia S, Bichakjian C, Boland G, Chandra S, Chen D, Chmielowski B, Choi J, DiMaio D, Dronca R, Fleming MD, Galan A, Guild S, Hu-Lieskovan S, Karakousis G, Kendra K, Kiuru M, Lange JR, Lanning R, Logan T, Materin M, Nelson K, Olson D, Olszanski AJ, Ott PA, Puzanov I, Rothermel L, Salama AK, Shannon A, Sharma R, Singh A, Stacey A, Tsai K, Wuthrick E, Xing Y, McMillian N, Espinosa S. Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 42297031

McConathy J, Koshkin VS, Menda Y, Rodon J, Goenka AH, Moy RH, Morse S, Demange A, Blumenstein L, Babaoglan B, Aimone P, Hope TA. Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 42223513

Pollyea DA, Altman JK, Assi R, Bachiashvili K, Bhatt VR, Fathi AT, Fedorov K, Foran JM, Gojo I, Goldberg A, Hall AC, Jonas BA, Levine MR, Mangan J, Mannis G, Marcucci G, Mims A, Moriarty K, Mustafa Ali M, Neff J, Nejati R, Olin R, Patel A, Percival ME, Perl A, Pettit K, Rao D, Ravandi F, Schwabkey Z, Shallis R, Stahl M, Stone RM, Thota S, Uy GL, Walker A, Wang E, Awotiwon A, Roth SL, Stehman K. NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 42297017

Aggarwal R, Oseran AS, Manrai AK, Marinacci LX, Bhatt DL, Yeh RW, Ho JE, Rodman A, Wadhera RK. Performance of Local Large Language Models for Adjudicating Heart Failure Hospitalizations. Circulation. 2026. PMID: 42224376

Beumer A, Carlson M, Arcuri AL, Maues J, Cowden J, Walker S, Shanahan K, Collins JL, Veach AJ, Rugo HS, Burkard ME, Kalinsky KM, Bardia A, Lustberg MB, Papautsky EL, Roberson ML. A Patient-Led Survey of Antibody Drug Conjugate Usage and Dosing for People Living With Metastatic Breast Cancer. Journal of Patient Experience. 2026. PMID: 42227000

Malangwa G, Banzi MO, Makupa G, Nnko G, Mwakipunda L, Rugengemanzi E, Karia A, Ramadhan A, Mashashi G, Idrisa C, Gisiri M, Kashabano J, Mabruk NA, Moturi M, Mushi B, Ndumbalo J, Kahesa C, Maunda K, DeBoer RJ, Mmbaga E, Lugina EL. The social and clinical profile of patients with ocular surface squamous cell carcinoma in Tanzania. BMC cancer. 2026. PMID: 42218433

Dent S, Nadler MB, Blaes A, Iqbal A, Ayettey HNG, Alvarez-Cardona J, Chan A, Koh ES, Mascunano RC, George M, Aryeetey NA, Howden EJ, Kazuhiro S, Latif N, Ozaki AF, Semple CJ, Ramalingan T, Iyenger NM, Rugo HS, Koczwara B. Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2026. PMID: 42209784

Aggarwal RR, Italiano A, Domchek SM, Goodman O, Postel-Vinay S, García-Donás J, Dorff T, Reichert ZR, Vinceneux A, Shore N, Marshall CH, Armenia J, Parr G, Kmieciak A, Lukashchuk N, Murina O, Slade D, Shah N, Loembé B, Dean E, Sanai E, Abida W. Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE Study. Cancer Research Communications. 2026. PMID: 42219553

Ramesh R, Osorio RC, Pekmezci M, Boreta L, Datta D, Alan N. Diagnosis and Management of Extranodal Rosai-Dorfman Disease Isolated to the Thoracic Spine: Systematic Review and Illustrative Case. World neurosurgery. 2026. PMID: 42214468

Timmerman J, Lavie D, Johnson NA, Avigdor A, Borchmann P, Andreadis C, Bazargan A, Gregory GP, Keane C, Tzoran I, Vucinic V, Zinzani PL, West RM, Pillai P, Marinello P, Herrera AF. Favezelimab plus pembrolizumab for anti-PD-1-refractory classic Hodgkin lymphoma: an open-label phase 1/2 study. Blood neoplasia. 2026. PMID: 42699247

Hawes MR, Safier J, Clark B, Pamatmat M, Bonniot C, Cheng C, Almazar R, Gillece J, Vijayaraghavan M. Implementing Trauma-Informed Training for Tobacco Use for Health Care Professionals in Two California Counties. Health promotion practice. 2026. PMID: 42187031

Feng Z, Gu Y, Zheng W, Pu D, Liu J, Chen G, Liu D, Zhang X, Ye F, Zhang S, Ai W, Huang L, Yu Z, Zhou J, Zhou Y, Qin P, Fang H, Wang Z, Ke W. Mechanically Adaptive Viscoelastic Grain-Boundary Regulation in Blade-Coated Tin-Lead Perovskites. ACS applied materials & interfaces. 2026. PMID: 42183636

Asiimwe E, Hu D, Cheng J, Wu AHB, Kushi LH, Huang FW, Kachuri L, Oni-Orisan A, Ziv E. Clinical Implications of the Duffy-Null Genotype in Patients on Azathioprine or Methotrexate in the All of Us Cohort. The journal of applied laboratory medicine. 2026. PMID: 42168119

Boutin CA, Callegari M, Florescu D, Nguyen MH, Kaul D, Avery R, Chong P, Fisher C, Limaye AP, Clough L, Pergam SA, Green M, Michaels MG, Danziger-Isakov L, Angarone M, Keefer L, Daud A, Lorenzo-Redondo R, Tan M, Ison MG. A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2026. PMID: 42177030

Duong N, Huynh DJ, Nikzad N, Kim WR, Shah N, Biggins SW, Kwong A. Reply: Validation of MELD 3.0 in 2 centers from different continents. Hepatology communications. 2026. PMID: 42172502